Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis"

Affiliations

¹ Department of Digestive Surgical Oncology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. Gabriel.liberale@bordet.be.
² Department of Statistics (Data Centre), Jules Bordet Institute, Université Libre de Bruxelles (ULB.), Brussels, Belgium.
³ Department of Digestive Surgery, IRIS Sud Hospitals (ULB), Brussels, Belgium.

Comment

Gabriel Liberale et al. Ann Surg Oncol. 2022 Nov.

. 2022 Nov;29(12):7933-7934.

doi: 10.1245/s10434-022-12514-z. Epub 2022 Sep 13.

¹ Department of Digestive Surgical Oncology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. Gabriel.liberale@bordet.be.
² Department of Statistics (Data Centre), Jules Bordet Institute, Université Libre de Bruxelles (ULB.), Brussels, Belgium.
³ Department of Digestive Surgery, IRIS Sud Hospitals (ULB), Brussels, Belgium.

No abstract available

Comment in

Reply to Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
Flood MP, Kong JCH, Heriot AG. Flood MP, et al. Ann Surg Oncol. 2022 Nov;29(12):7935-7936. doi: 10.1245/s10434-022-12522-z. Epub 2022 Sep 14. Ann Surg Oncol. 2022. PMID: 36103013 No abstract available.

The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis.
Flood MP, Kong JCH, Wilson K, Mohan H, Waters PS, McCormick JJ, Warrier SK, Tie J, Ramsay R, Michael M, Heriot AG. Flood MP, et al. Ann Surg Oncol. 2022 Oct;29(11):6619-6631. doi: 10.1245/s10434-022-11699-7. Epub 2022 Apr 9. Ann Surg Oncol. 2022. PMID: 35397737 Free PMC article.

1. Flood MP, Kong JC, Wilson K, Mohan H, Waters PS, McCormick JJ, et al. The impact of neoadjuvant chemotherapy on the surgical management of colorectal peritoneal metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11699-7 . - DOI - PubMed - PMC
1. Repullo D, Barbois S, Leonard D, Bohlok A, Van den Audenaeren E et al. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective analysis. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2021.01.018
1. Rovers KP, Bakkers C, Simkens GA, et al. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II–III, randomised, superiority study (CAIRO6). BMC Cancer. 2019;19(1):390. https://doi.org/10.1186/s12957-018-1554-8 . - DOI - PubMed - PMC